The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Miromatrix Medical Inc (MIRO) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.01, or -0.30%, to $3.31. The Miromatrix Medical Inc has recorded 11,789 volume in the after hours trading session. The stock was recently discussed on Yahoo Finance as it revealed that United Therapeutics to Acquire Miromatrix Medical.
Miromatrix Medical Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $3.32 and fluctuated between $3.3200 as its day high and $3.2800 as its day low. The current market capitalization of Miromatrix Medical Inc is $90.67M. A total of 1.04 million shares were traded on the day, compared to an average of 94.24K shares.
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, MIRO has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 17 BUYs and 2 SELLs from insiders. Insiders purchased 613,505 shares during that period but sold 16,062.
In the most recent transaction, ERB JOHN L bought 31,250 shares of MIRO for 1.60 per share on Mar 10. After the transaction, the Director now owns 56,260 company shares. In a previous transaction on Mar 10, Heine Lisa Wipperman bought 31,250 shares at 1.60 per share. MIRO shares that Director owns now total 80,155.
Among the insiders who bought shares, Burke William P. Mr. acquired of 31,250 shares on Mar 10 at a per-share price of $1.60. This resulted in the Director holding 80,155 shares of MIRO after the transaction. In another insider transaction, Douglas James Michael bought 31,250 shares at $1.60 per share on Mar 10. Company shares held by the CHIEF FINANCIAL OFFICER now total 51,250.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for MIRO in the last 3 months, the mean price target is $3.13 with high estimates of $3.25 and low estimates of $3.00. In terms of 52-week highs and lows, MIRO has a high of $4.50 and a low of $0.91.
As of this writing, MIRO has an earnings estimate of -$0.21 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.18 per share and a lower estimate of -$0.24. The company reported an EPS of -$0.33 in the last quarter, which was -13.80% lower than expectations of -$0.29.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. MIRO’s latest balance sheet shows that the firm has $52.81M in Cash & Short Term Investments as of fiscal 2021. There were $830.65k in debt and $4.56M in liabilities at the time. Its Book Value Per Share was $0.79, while its Total Shareholder’s Equity was $54.13M.
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MIRO is Buy with a score of 5.00.